ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MDT Medtronic PLC

80.89
0.65 (0.81%)
02 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Medtronic PLC NYSE:MDT NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.65 0.81% 80.89 81.73 79.99 79.99 5,366,118 01:00:00

MDT SHAREHOLDER ALERT: Jakubowitz Law Reminds Medtronic Shareholders of a Lead Plaintiff Deadline of November 7, 2022

14/10/2022 10:45am

PR Newswire (US)


Medtronic (NYSE:MDT)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Medtronic Charts.

NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Medtronic plc (NYSE: MDT).

To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/medtronic-plc-loss-submission-form/?id=32611&from=4

This lawsuit is on behalf of persons and entities who purchased or otherwise acquired Medtronic common stock between June 8, 2019, and May 25, 2022, inclusive.

Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until November 7, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

According to a filed complaint, Medtronic plc issued materially false and/or misleading statements and/or failed to disclose that: (1) Medtronic's product quality control systems were inadequate; (2) Medtronic had failed to comply with numerous regulations regarding risk assessment, corrective and preventive action, complaint handling, device recalls, and reporting of adverse events; (3) these failures increased the risk of regulatory investigation and action; (4) as a result of the Company's misconduct, the U.S. Food and Drug Administration would delay the approval of additional Medtronic MiniMed devices, including the MiniMed 780G; (5) these delays in product approvals, as well as the Company's need to improve its quality control systems, would negatively affect the Company's financial performance and cause Medtronic to fall further behind its competitors; and (6) as a result of the foregoing, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

Cision View original content:https://www.prnewswire.com/news-releases/mdt-shareholder-alert-jakubowitz-law-reminds-medtronic-shareholders-of-a-lead-plaintiff-deadline-of-november-7-2022-301649229.html

SOURCE Jakubowitz Law

Copyright 2022 PR Newswire

1 Year Medtronic Chart

1 Year Medtronic Chart

1 Month Medtronic Chart

1 Month Medtronic Chart

Your Recent History

Delayed Upgrade Clock